SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950123-10-107801
Filing Date
2010-11-22
Accepted
2010-11-22 16:08:38
Documents
1
Group Members
CHAI TRUST COMPANY, LLCEGI-FUND (08-10) INVESTORS, L.L.C.EGI-MBRK, L.L.C.SZ INVESTMENTS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A c08840sc13dza.htm SC 13D/A 65910
  Complete submission text file 0000950123-10-107801.txt   68071
Mailing Address 20425 SENECA MEADOWS PARKWAY, GERMANTOWN, MD 20876
Business Address 20425 SENECA MEADOWS PARKWAY GERMANTOWN MD 20878 (301) 944-6600
MiddleBrook Pharmaceuticals, Inc. (Subject) CIK: 0001161924 (see all company filings)

IRS No.: 522208264 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79326 | Film No.: 101208882
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606
Business Address TWO NORTH RIVERSIDE PLAZA SUITE 600 CHICAGO IL 60606 312-466-3301
EGI-MBRK, L.L.C. (Filed by) CIK: 0001444489 (see all company filings)

IRS No.: 262919644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A